External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.

MLA

Gandaglia, Giorgio, et al. “External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.” European Urology, vol. 78, no. 2, Aug. 2020, pp. 138–42. EBSCOhost, https://doi.org/10.1016/j.eururo.2020.03.023.

APA

Gandaglia, G., Martini, A., Ploussard, G., Fossati, N., Stabile, A., De Visschere, P., Borgmann, H., Heidegger, I., Steinkohl, F., Kretschmer, A., Marra, G., Mathieu, R., Surcel, C., Tilki, D., Tsaur, I., Valerio, M., Van den Bergh, R., Ost, P., Gontero, P., & Montorsi, F. (2020). External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection. European Urology, 78(2), 138–142. https://doi.org/10.1016/j.eururo.2020.03.023

Chicago

Gandaglia, Giorgio, Alberto Martini, Guillaume Ploussard, Nicola Fossati, Armando Stabile, Pieter De Visschere, Hendrik Borgmann, et al. 2020. “External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.” European Urology 78 (2): 138–42. doi:10.1016/j.eururo.2020.03.023.